benztropine mesylate

Drug ingredient

CAS 132-17-2

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

US productionNot reported

Import value, 2024$171M

Top sourceSwitzerland 40%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293979 · basket

These shares come from HS customs code 293979, which covers 60 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

CH 40%SwitzerlandCN 18%ChinaIT 14%ItalyDE 13%GermanyIN 10%India

Australia
Poland
Belgium
Taiwan
Canada
Japan
Spain
Mexico
New Zealand
Slovenia
Israel

28 FDA-registered drug labelers

A-S Medication Solutions

American Health Packaging

Aphena Pharma Solutions - Tennessee, LLC

Apothecon Pharmaceuticals Pvt Ltd

Bryant Ranch Prepack

Chartwell RX, LLC.

Cipla USA Inc.

DIRECT RX

Endo USA, Inc.

ESCIENTIA ADVANCED SCIENCES PRIVATE LIMITED

Fine Chemicals Corporation (PTY) Ltd.

Fresenius Kabi USA, LLC

Harman Finochem Limited

Hikma Pharmaceuticals USA Inc.

KALINTIS HEALTHCARE PRIVATE LIMITED

Leading Pharma, LLC

Major Pharmaceuticals

Marlex PHARMACEUTICAL, INC

Navinta LLC

NCS HealthCare of KY, LLC dba Vangard Labs

Par Active Technologies Private Limited

Proficient Rx LP

QUAGEN PHARMACEUTICALS LLC

REMEDYREPACK INC.

ScieGen Pharmaceuticals Inc

Siegfried Grafton, Inc.

SUNRISE PHARMACEUTICAL, INC

Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors

Health

Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

•Benztropine Mesylate

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

No Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

to be discontinued
Benztropine Mesylate Injection
Shortage listed since January 27, 2026

See all current drug shortages

Vendor Pricing

$55.00/gApexbio Technology LLC

CountryUnited States

Pack$55.00 / 1 g

Purity99.41%

Vendors4 available

Prices reflect listed pack sizes. Small research packs run far above bulk rates.

3 more vendors

Vendor	Country	$/g	Pack	Purity
A2B Chem LLC (1 week)	United States	$55.90	10 g	95%
Labotest KG	Germany	$453.00	1000 mg	90%
Key Organics Ltd.	United Kingdom	$6900.00	10 mg	98%

Chemical Identity

CAS132-17-2

PubChem CID8584

DTXSIDDTXSID0045096

FormulaC22H29NO4S

Mol. Weight403.5 g/mol

SMILESCN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O

Data Sources

PubChem · compound 8584Retrieved 2026-04-07
FDA National Drug Code directoryRetrieved 2026-04-25
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

benztropine mesylate (CAS 132-17-2) https://chemicalindependence.com/chemical/132-17-2/ PubChem: 8584. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/8584 FDA National Drug Code directory: CAS 132-17-2. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 132-17-2. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293979 for CAS 132-17-2. Reporting year: 2024. https://usatrade.census.gov/